WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott released the following statement on the Department of Health and Human Services’ proposal requiring drug companies to disclose the list price of prescription drugs in television ads:
“We share the Administration’s goal of reducing prescription drug prices. Pharmacy benefit managers (PBMs) foster competition among drugmakers, resulting in lower costs for consumers.
We believe that list prices of drugs should be included in drug manufacturers’ communications with prescribers to help patients make informed treatment choices.
The most direct way to reduce costs and improve access to prescription drugs is for drugmakers to cut their prices, and we look forward to working with the Administration and Congress to accomplish this goal.”
PCMA issues statement on proposal requiring list prices of drugs in TV ads
Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C.
Latest
Sanofi and USA Pickleball launch COVID-19 education campaign
Despite their risk of serious illness from COVID-19, nearly 70% of adults 65 and older remain unvaccinated, in part due to concerns about potential side effects
AAM: Generics and biosimilars saved U.S. health system $496 billion in 2025
Generics and biosimilars represented 89% of U.S. prescriptions but only 12% of prescription drug spending in 2025, according to AAM.
FMI issues statement on August 2026 CPI Food Price numbers
“The August CPI numbers bring some modest relief for grocery shoppers,” FMI said.
Study links mRNA flu vaccine to sustained immune response
Researchers found an mRNA flu vaccine produces broader antibodies than conventional ones, offering clues for more lasting influenza protection.